Influence of new 1,3,4-thiadiazines on platelet aggregation in vitro and ex vivo

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 73, Issue 8, 2010, Pages 21-25

  Logvinova, Y S ^a   Vasil'eva, T M ^a   Makarov, V A ^a   Chupakhin, O N ^b   Sidorova, L P ^b   Perova, N M ^b   Rusinov, V L ^b  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^b URAL FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

1,3,4 thiadiazines; Platelet aggregation

Indexed keywords

1,3,4 THIADIAZINE DERIVATIVE; 1,3,4 THIADIAZINE H 30; 1,3,4 THIADIAZINE L 19; 1,3,4 THIADIAZINE L 37; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; DRUG EFFICACY; EX VIVO STUDY; HEMOSTASIS; HUMAN; IN VITRO STUDY; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ANIMALS; ARACHIDONIC ACID; DRUG EVALUATION, PRECLINICAL; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS; THIADIAZINES;

EID: 77957366081     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. T. Aboul-Fadl, M. A. Hussein, A. N. El-Shorbagi, et al., Arch Pharm (Weinheim), 335(9), 438-442 (2002).
2. G. Born, Nature (London), 194, 927-929 (1962).
3. N. Campillo, C. García, P. Goya, et al., J. Med. Chem., 42(10), 1698-1704 (1999).
4. M. M. Hoffman and D. M. Monroe, Curr. Hematol. Rep., 4(5), 391-396 (2005).
5. X. Ji, Z. Zhong, X. Chen, et al., Bioorg. Med. Chem. Lett., 17(15), 4275-4279 (2007).
6. P. Karegoudar, D. J. Prasad, M. Ashok, et al., Eur. J. Med. Chem., 43(4), 808-815 (2008).
7. A. B. Ozcelik, S. Ersan, A. U. Ural, et al., Arzneimittelforschung., 57(8), 554-559 (2007).
8. K. Rehse, U. Brümmer, and E. Unsöld, Pharmazie., 53(12), 820-824 (1998).
9. J. M. Stassen, J. Arnout, H. Deckmyn, et al., Current Med. Chem., 11, 2245-2260 (2004).
10. R. Tedesco, A. N. Shaw, R. Bambal., et al., J. Med. Chem., 49(3), 971-983 (2006).